AARDEX Group has announced its partnership with Mevia. The partnership is an opportunity to test and pilot Mevia’s reusable hardware, which transmits when a dose is extracted, with AARDEX’s MEMS AS and MEMS Mobile technology.
MEMS AS medication adherence software measures medication adherence in clinical trials, while MEMS Mobile provides an app helping participants to stay on track.
Mepill and Medose detect when a trace is broken and transfers data on the exact dose taken. The user is updated through an e-ink display or a LED light on the device. Fully reusable, the cavities of the dose packages can be filled in automated machines by the pharmacy, ontract manufacturing organization, or manually.
AARDEX Partners with Mevia to Test Evolution of Real-Time Adherence Technology. (2023, June 12). AARDEX Group.
Driving Diversity with the Integrated Research Model
October 16th 2024Ashley Moultrie, CCRP, senior director, DEI & community engagement, Javara discusses current trends and challenges with achieving greater diversity in clinical trials, how integrated research organizations are bringing care directly to patients, and more.
AI in Clinical Trials: A Long, But Promising Road Ahead
May 29th 2024Stephen Pyke, chief clinical data and digital officer, Parexel, discusses how AI can be used in clinical trials to streamline operational processes, the importance of collaboration and data sharing in advancing the use of technology, and more.
The Rise of Predictive Engagement Tools in Clinical Trials
November 22nd 2024Patient attrition can be a significant barrier to the success of a randomized controlled trial (RCT). Today, with the help of AI-powered predictive engagement tools, clinical study managers are finding ways to proactively reduce attrition rates in RCTs, and increase the effectiveness of their trial. In this guide, we look at the role AI-powered patient engagement tools play in clinical research, from the problems they’re being used to solve to the areas and indications in which they’re being deployed.